- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Drafting Process and key Points of ICH Q2(R2) and Q14 Guideline (2)
-
- HIYAMA Yukio
- Rapporteur of ICH Q2Q14 Expert Working Group Visiting Scientist, Division of Drugs, National Institute of Health Sciences
Bibliographic Information
- Other Title
-
- ICH Q2(R2),Q14ガイドラインの作成状況と論点解説─(2)
Search this article
Description
<p>This article describes the drafting process and key points of ICH Q2(R2)(Analytical Validation) and ICH Q14(Analytical Development). The harmonization effort started in 2018 and the two documents are being drafted by one Expert Working Group. The drafts for public consultation will be published in early 2022. The revised Q2 will include spectroscopic procedures, procedures used for biologics, multivariate analysis based procedures, etc. The new Q14 will cover Enhanced (Quality by Design) development approach. Q14 emphasizes that the enhanced knowledge supports robust analytical procedures and their effective lifecycle management.</p>
Journal
-
- PDA Journal of GMP and Validation in Japan
-
PDA Journal of GMP and Validation in Japan 23 (2), 45-52, 2021
Parenteral Drug Association Japan Chapter
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390009073678452480
-
- NII Article ID
- 130008137490
-
- ISSN
- 18811728
- 13444891
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed